New guidance to tackle medicine supply shortages in the UK’s National Health Service was published yesterday by the Department of Health. The guidance - Best Practice for Ensuring the Efficient Supply and Distribution of Medicines to Patients - is the result of months of work with stakeholders throughout the supply chain. It sets out in writing procedures to help ensure UK patients can obtain their medication.
The guidance is welcomed by the Association of the British Pharmaceutical Industry (ABPI) as a step in the right direction. But the ABPI warned there is still much to be done to ensure UK patients do not lose out because of the activities of a minority in the supply chain trading medicines for profit, exploiting the low cost of UK drugs and fluctuating exchange rates.
“Stronger govt action needed”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze